Author

Yuki Kagoya

Keio UniversityORCID 0000-0002-6216-6730Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 1

Frequent Co-Authors

Brian D. BurtiD· 2 shared Dalam LyiD· 2 shared Dong-Hoon HaniD· 2 shared Evey Y. F. ZhengiD· 2 shared Fumie IharaiD· 2 shared Kayoko SasoiD· 2 shared Marcus Otho ButleriD· 2 shared Mark David MindeniD· 2 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Brian D. BurtORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintMar 3, 2026

Exploiting HLA-II Promiscuity via Peptide Terminal Overhang Recognition for Pan-Allelic and Tumor-Selective AML Immunotherapy

Saori Fukao, Evey Y. F. Zheng, Fumie Ihara…·Naoto Hirano

This paper identifies an MPO-derived epitope promiscuously presented by HLA-II molecules and develops a pan-allelic antibody that selectively targets AML cells while sparing normal myeloid cells.

DOI 10.64898/2026.03.01.708866

humanproteomics

𝕏 PostBluesky

ImmunologybioRxivPreprintJun 30, 2025

Peptide-Specific CAR T cells Recognize WT1 Promiscuously Presented by Diverse HLA Class II Alleles

Chung-Hsi Wang, Evey Y. F. Zheng, Toshiki Ochi…·Naoto Hirano

This paper develops WT1-specific CAR T cells that recognize the WT1330-348 peptide across 18 HLA-II alleles, enabling broad therapeutic application.

DOI 10.1101/2025.06.30.660492

humanexperimental assay

𝕏 PostBluesky